Hair and Nail Tonic
NDC 61096-1022, Avena, DNA, Elaeis, Glandula suprarenalis suis, Hamamelis, Hepar suis, Kali sulph, Nat mur, Nicotinamidum, Phosphoricum ac, Pituitarum posterium, Riboflavinum, Thiaminum hydrochloricum, Thuja occ, Thyroidinum, Urtica ur., liquid, from Eight and Company L.L.C.
- Product NDC
- 61096-1022
- Status
- Listed
- Labeler
- Eight and Company L.L.C
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61096-1022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AVENA SATIVA FLOWERING TOP4 [hp_X]/41mL
- HERRING SPERM DNA12 [hp_X]/41mL
- ELAEIS GUINEENSIS FRUIT15 [hp_X]/41mL
- SUS SCROFA ADRENAL GLAND30 [hp_C]/41mL
- HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK4 [hp_X]/41mL
- PORK LIVER6 [hp_X]/41mL
- POTASSIUM SULFATE30 [hp_C]/41mL
- SODIUM CHLORIDE200 [hp_C]/41mL
- NIACINAMIDE6 [hp_X]/41mL
- PHOSPHORIC ACID4 [hp_X]/41mL
- SUS SCROFA PITUITARY GLAND10 [hp_X]/41mL
- RIBOFLAVIN8 [hp_X]/41mL
- THIAMINE HYDROCHLORIDE6 [hp_X]/41mL
- THUJA OCCIDENTALIS LEAFY TWIG200 [hp_C]/41mL
- THYROID, UNSPECIFIED30 [hp_C]/41mL
- URTICA URENS WHOLE4 [hp_X]/41mL
Pharmacologic classes
Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61096-1022-1 | 61096102201 | 1 BOTTLE, SPRAY in 1 CARTON (61096-1022-1) / 41 mL in 1 BOTTLE, SPRAY |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 61096-1022 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61096-1022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61096-1022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.